Cargando…

The level of urinary semaphorin3A is associated with disease activity in patients with minimal change nephrotic syndrome

Semaphorin3A is a secreted protein known to be involved in organogenesis, immune responses and cancer. In the kidney, semaphorin3A is expressed in the glomerular podocytes, distal tubules and collecting tubules, and believed to play a role in the regulation of the kidney development and function. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inoue-Torii, Akiko, Kitamura, Shinji, Wada, Jun, Tsuji, Kenji, Makino, Hirofumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489052/ https://www.ncbi.nlm.nih.gov/pubmed/28790860 http://dx.doi.org/10.2147/IJNRD.S132980

Ejemplares similares

Semaphorin3A-Inhibitor Ameliorates Doxorubicin-Induced Podocyte Injury
por: Sang, Yizhen, et al.
Publicado: (2020)

MicroRNAs as Biomarkers for Nephrotic Syndrome
por: Tsuji, Kenji, et al.
Publicado: (2020)

Role of Semaphorin 3A in Kidney Development and Diseases
por: Sang, Yizhen, et al.
Publicado: (2023)

Iliac Arterial Thrombosis in Minimal Change Nephrotic Syndrome
por: Nagayama, Yoshikuni, et al.
Publicado: (2022)

Alogliptin-Induced Minimal Change Nephrotic Syndrome and Interstitial Nephritis
por: Shima, Hisato, et al.
Publicado: (2019)

Pathogenesis of minimal change nephrotic syndrome: an immunological concept
por: Kim, Seong Heon, et al.
Publicado: (2016)

Quality of Life in Patients with Minimal Change Nephrotic Syndrome
por: Shutto, Yoshiko, et al.
Publicado: (2013)

Cerebral infarction in patient with minimal change nephrotic syndrome
por: Babu, A., et al.
Publicado: (2013)

Efficacy of a mitochondrion-targeting agent for reducing the level of urinary protein in rats with puromycin aminonucleoside-induced minimal-change nephrotic syndrome
por: Fujii, Yuko, et al.
Publicado: (2020)

The therapeutic potential of synthetic human atrial natriuretic peptide in nephrotic syndrome: a randomized controlled trial
por: Kanzaki, Motoko, et al.
Publicado: (2012)

Urinary indices in nephrotic syndrome
por: Sahay, M.
Publicado: (2011)

Podocyte autophagy is associated with foot process effacement and proteinuria in patients with minimal change nephrotic syndrome
por: Ogawa-Akiyama, Ayu, et al.
Publicado: (2020)

Mechanism Underlying Selective Albuminuria in Minimal Change Nephrotic Syndrome
por: Tojo, Akihiro
Publicado: (2019)

Tozinameran: Nephrotic syndrome and minimal change disease : case report
Publicado: (2022)

Significance of urinary fatty acid-binding protein 4 level as a possible biomarker for the identification of minimal change disease in patents with nephrotic-range proteinuria
por: Tanaka, Marenao, et al.
Publicado: (2020)

Urinary CD 80 in Nephrotic Syndrome: A Biomarker to Distinguish Minimal Change Disease From Other Glomerular Diseases
por: Mishra, Om P.
Publicado: (2020)

Urinary and plasma proteomics to discover biomarkers for diagnosing between diabetic nephropathy and minimal change nephrotic syndrome or membranous nephropathy
por: Araumi, Akira, et al.
Publicado: (2021)

DNA methylation changes between relapse and remission of minimal change nephrotic syndrome
por: Kobayashi, Yasuko, et al.
Publicado: (2012)

A Case of Nephrotic Syndrome With Minimal-Change Disease and Waldenstrom’s Macroglobulinemia
por: Grabe, Darren W., et al.
Publicado: (2013)

Significance of Electron Dense Deposits in Patients with Minimal Change Nephrotic Syndrome
por: Kim, Sae Yoon, et al.
Publicado: (2012)

Minimal Change Nephrotic Syndrome in a Child with Systemic Lupus Erythematosus
por: Deshpande, Pankaj V.
Publicado: (2023)

High Albumin Clearance Predicts the Minimal Change Nephrotic Syndrome Relapse
por: Kuno, Hideaki, et al.
Publicado: (2023)

Secretomes from Mesenchymal Stem Cells against Acute Kidney Injury: Possible Heterogeneity
por: Tsuji, Kenji, et al.
Publicado: (2018)

Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Renal Diseases
por: Tsuji, Kenji, et al.
Publicado: (2020)

Potential Strategies for Kidney Regeneration With Stem Cells: An Overview
por: Tsuji, Kenji, et al.
Publicado: (2022)

Yellow nail syndrome accompanied by minimal-change nephrotic syndrome: A case report
por: Zhang, Ya-Nan, et al.
Publicado: (2022)

Efficacy of cyclosporine combination therapy for new-onset minimal change nephrotic syndrome in adults
por: Fujiwara, Akira, et al.
Publicado: (2014)

Role of basophils in the pathogenesis of minimal change nephrotic syndrome: A literature review
por: PAN, QINGJUN, et al.
Publicado: (2014)

Clinical Characteristics and Outcomes of Adults with Nephrotic Syndrome Due to Minimal Change Disease
por: Lionaki, Sophia, et al.
Publicado: (2021)

Outcomes of minimal change disease without nephrotic range proteinuria
por: Son, Hyung Eun, et al.
Publicado: (2023)

Co-occurrence of Three Systemic Diseases: ANCA-associated Vasculitis, Sjögren's syndrome and Sarcoidosis
por: Tsuji, Kenji, et al.
Publicado: (2022)

Successfully Treated Femoral Artery Thrombosis in a Patient with Minimal Change Nephrotic Syndrome
por: Lee, Ji Kyoung, et al.
Publicado: (2013)

Tozinameran: Minimal change disease with nephrotic syndrome and acute kidney injury: case report
Publicado: (2021)

mRNA-1273: Nephrotic syndrome secondary to minimal change disease: case report
Publicado: (2021)

mRNA-1273: Nephrotic syndrome secondary to minimal change disease: case report
Publicado: (2021)

Tozinameran: De novo minimal change disease (MCD) and nephrotic syndrome: case report
Publicado: (2022)

Albumin Clearance as a Novel Predictor of Relapse in Adults with Minimal Change Nephrotic Syndrome
por: Yamamoto, Ryohei, et al.
Publicado: (2023)

Predictability of Urinary CD80 in the Relapse of Primary Nephrotic Syndrome
por: Liao, Juan, et al.
Publicado: (2017)

A case of focal segmental glomerulosclerosis in an adult patient with hypogammaglobulinemia superimposed on membranoproliferative glomerulonephritis in childhood
por: Tsuji, Kenji, et al.
Publicado: (2012)

Membranous nephropathy with acquired factor V inhibitor: a case report
por: Kitamura, Shinji, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dom0d6f1nbr6ctp4fmln0m4dth